Published in Hepatitis Weekly, June 11th, 2001
Details of this molecular manipulation could aid researchers in developing drug designs against HDV.
Yuki Yamaguchi and colleagues in Japan found that the sequence of hepatitis delta antigen is similar to a subunit of a human protein called NELF, which inhibits transcription elongation by RNA polymerase II ("Stimulation of RNA polymerase II elongation by hepatitis delta antigen," Science, May 31, 2001).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.